Northwell Health Cancer Institute appoints melanoma specialist deputy physician-in-chief
Click Here to Manage Email Alerts
Richard D. Carvajal, MD, has been appointed deputy physician-in-chief and director of medical oncology at Northwell Health Cancer Institute.
Carvajal — recognized for his expertise in melanoma and early-phase drug development — also will serve as R.J. Zuckerberg chair in medical oncology.
He will oversee medical oncology across Northwell’s cancer network. He also will collaborate with the cancer institute’s two other deputy physicians-in-chief, who specialize in radiation oncology and surgical oncology.
Carvajal previously served as director of experimental therapeutics and director of the melanoma service at Columbia University Irving Medical Center, as well as co-lead of the precision oncology and systems biology program at Herbert Irving Comprehensive Cancer Center. He also led the developmental therapeutics service at Memorial Sloan Kettering Cancer Center.
“Dr. Carvajal is an innovator in clinical care, immunotherapy and leading-edge research in the field of melanoma and other cancers,” Richard Barakat, MD, physician-in-chief and director of the Northwell Health Cancer Institute, as well as senior vice president of the health system’s service line, said in a press release. “We are very fortunate to have such an esteemed medical oncologist and cancer researcher join the cancer institute’s leadership team. Our colleagues are looking forward to closely working with Dr. Carvajal to help design new clinical trials and treatment options more quickly to help patients fighting not only melanoma but other complex cancers.”
Read more about
Click Here to Manage Email Alerts